Intravenous nicorandil prevents thiamylal-fentanyl-induced bronchoconstriction in humans

Critical Care Medicine

Volumn 31, Issue 2, 2003, Pages 485-490

  Wajima, Zen'ichiro ^a   Yoshikawa, Tatsusuke ^a,b,c   Ogura, Akira ^d   Imanaga, Kazuyuki ^a   Shiga, Toshiya ^a   Inoue, Tetsuo ^a   Ogawa, Ryo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Hakujikai Memorial Hospital   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchorelaxant; Fentanyl; Induced bronchoconstriction; Nicorandil; Thiamylal

Indexed keywords

FENTANYL; NICORANDIL; NITRATE; NITROUS OXIDE; OXYGEN; PLACEBO; POTASSIUM CHANNEL STIMULATING AGENT; SODIUM CHLORIDE; THIAMYLAL; VECURONIUM;

AIRWAY RESISTANCE; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GUINEA PIG; HEART RATE; HUMAN; LUNG COMPLIANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRACHEA;

ADULT; ANESTHETICS, INTRAVENOUS; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; INJECTIONS, INTRAVENOUS; MALE; NICORANDIL; PROSPECTIVE STUDIES; THIAMYLAL;

EID: 0037326483     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000049950.58587.84     Document Type: Article

References (28)

1. Markham A, Plosker GL, Goa KL. Nicorandil: An updated review of its use in ischemic heart disease with emphasis on its cardioprotective effects. Drugs 2000; 60:955-974
2. Kato K: Haemodynamic and clinical effects of an intravenous potassium channel opener: A review. Eur Heart J 1993; 14:40-47
3. McNeil JJ, Krum H: Cardiovascular disorders. In: Avery's Drug Treatment. Fourth Edition. Speight TM, Holford NHG (Eds). Auckland, New Zealand, Adis International Limited, 1997, pp 809-896
4. Allen SL, Foster RW, Morgan GP, et al: The relaxant action of nicorandil in guinea-pig isolated trachealis. Br J Pharmacol 1986; 87:117-127
5. Nagai H, Kitagaki K, Goto S, et al: Effect of three novel K channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma. Jpn J Phamacol 1991; 56:13-21
6. Wajima Z, Yoshikawa T, Ogura A, et al: Intravenous colforsin daropate, a water-soluble forskolin derivative, prevents thiamylalfentanyl-induced bronchoconstriction in humans. Crit Care Med 2002; 30:820-826
7. Petros AJ, Lamond CT, Bennett D: The Bicore pulmonary monitor: A device to assess the work of breathing while weaning from mechanical ventilation. Anaesthesia 1993; 48:985-988
8. Banner MJ, Kirby RR, Blanch PB, et al: Decreasing imposed work of the breathing apparatus to zero using pressure-support ventilation. Crit Care Med 1993; 21:1333-1338
9. Thomas AM, Turner RE, Tenholder MF: Esophageal pressure measurements in cardiopulmonary exercise testing. Chest 1997; 112:829-832
10. 2-adrenergic agonist after tracheal intubation. Anesth Analg 1996; 83:238-241
11. Wright PE, Marini JJ, Bernard GR: In vitro and in vivo comparison of endotracheal tube airflow resistance. Am Rev Respir Dis 1989; 140:10-16
12. Yamazaki Y, Yamakage M, Ujike Y, et al: Changes in work of breathing during continuous positive airway pressure with increased airway resistance. Chest 1994; 105:860-867
13. Nathan SD, Ishaaya AM, Koerner SK, et al: Prediction of minimal pressure support during weaning from mechanical ventilation. Chest 1993; 103:1215-1219
14. Berry, A, Brimacombe J, Keller C, et al: Pulmonary airway resistance with the endotracheal tube versus laryngeal mask airway in paralyzed anesthetized adult patients. Anesthesiology 1999; 90:395-397
15. Wu RSC, Wu KC, Sum DCW, et al: Comparative effects of thiopentone and propofol on respiratory resistance after tracheal intubation. Br J Anaesth 1996; 77:735-738
16. Williams AJ, Lee TH, Cochrane GM, et al: Attenuation of nocturnal asthma by cromakalim. Lancet 1990; 336:334-336
17. Nakae I, Quan L, Hashimoto K, et al: Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs. Cardiovasc Drugs Ther 1994; 8:137-145
18. Hofmann F, Ludwig A, Pfeifer A: Cyclic GMP and the control of airways smooth muscle tone. In: Airway Smooth Muscle: Biochemical Control of Contraction and Relaxation. Raeburn D, Giembycz MA (Eds). Basel, Birkhäuser, 1994, pp 253-270
19. Rolla G, Bucca C, Brussino L: Effect of inhaled norepinephrine on the nitroglycerin-induced bronchodilation in asthmatics. Chest 1995; 107:169-172
20. 2-agonist-induced bronchodilatation in asthmatics. Pulm Pharmacol 1995; 8:137-141
21. Nijkamp FP, Folkerts G: Nitric oxide and bronchial hyperresponsiveness. Arch Int Pharmacodyn Ther 1995; 329:81-96
22. Buckle DR: Prospects for potassium channel activators in the treatment of airways obstruction. Pulm Pharmacol 1993; 6:161-169
23. + channels in airway smooth muscle as estimated from actions of KC 128 and levcromakalim. Br J Pharmacol 1994; 113:889-897
24. Ichinose M, Barnes PJ: A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways. J Pharmacol Exp Ther 1990; 252:1207-1212
25. Gal TJ: Bronchial hyperresponsiveness and anesthesia: Physiologic and therapeutic perspectives. Anesth Analg 1994; 78:559-573
26. Kinoshita M, Nishikawa S, Sawamura M, et al: Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris. Am J Cardiol 1986; 58: 733-738
27. Camm AJ, Maltz MB: A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Am J Cardiol 1989; 63:61J-65J
28. Arnold JMO, Kowey PR, Wolf DL, et al: Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain. Int J Cardiol 1994; 44:203-215